Study to Evaluate the Immune Response to Pneumococcal Vaccine in Alefacept-treated Adults With Chronic Plaque Psoriasis

NCT00493324 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

43

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Plaque Psoriasis

Interventions

DRUG: alefacept
DRUG: polyvalent pneumococcal vaccine

Sponsor

Astellas Pharma Inc